Anthony Man

636 total citations
8 papers, 536 citations indexed

About

Anthony Man is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Anthony Man has authored 8 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Anthony Man's work include Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anthony Man is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anthony Man collaborates with scholars based in United Kingdom, Switzerland and Hungary. Anthony Man's co-authors include Katalin Csermak, P. A. Campochiaro, Martin Pruschy, Stephan Bodis, T. O'Reilly, Stephan Ruetz, Tim Meyer, J M Wood, Tom Brown and Brigitte Roos and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacokinetics and Pharmacodynamics and The Hematology Journal.

In The Last Decade

Anthony Man

8 papers receiving 520 citations

Peers

Countries citing papers authored by Anthony Man

Since Specialization

Citations

This map shows the geographic impact of Anthony Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Man more than expected).

Fields of papers citing papers by Anthony Man

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Man. The network helps show where Anthony Man may publish in the future.

Co-authorship network of co-authors of Anthony Man

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Man. A scholar is included among the top collaborators of Anthony Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Man. Anthony Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Modelling and Simulation in the Development and use of Anti-Cancer Agents: An Underused Tool? 2004 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Leon Aarons, Mats O. Karlsson, Anthony Man, France Mentré, Peter Nygren, Amy Racine, Hans Schaefer, Jean‐Louis Steimer, Iñaki F. Trocóniz, Achiel Van Peer, (unknown)	13
2	Multiple-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers 2004 ·Antimicrobial Agents and Chemotherapy ·Anne Schmitt‐Hoffmann, (unknown), Brigitte Roos, Michael Schleimer, (unknown), (unknown), Tom Brown, Anthony Man, E. Weidekamm	70
3	Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers 2004 ·Antimicrobial Agents and Chemotherapy ·Anne Schmitt‐Hoffmann, Brigitte Roos, Michael Schleimer, (unknown), Anthony Man, (unknown), Tom Brown, (unknown), E. Weidekamm, Péter Kovács	87
4	A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C 2002 ·The Hematology Journal ·Andres Virchis, K. Ganeshaguru, Stephen L. Hart, Dylan T. Jones, Linda Fletcher, (unknown), R G Wickremasinghe, Anthony Man, Katalin Csermak, Thomas Meyer, Doriano Fabbro, (unknown), (unknown), H. G. Prentice, Atul Mehta	27
5	Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. 2002 ·PubMed ·K. Ganeshaguru, R G Wickremasinghe, Dylan T. Jones, (unknown), (unknown), Andres Virchis, H. G. Prentice, A. Victor Hoffbrand, Anthony Man, (unknown), Katalin Csermak, Atul Mehta	40
6	PKC412--a protein kinase inhibitor with a broad therapeutic potential. 2000 ·PubMed ·(unknown), Stephan Ruetz, Stephan Bodis, Martin Pruschy, Katalin Csermak, Anthony Man, P. A. Campochiaro, J M Wood, T. O'Reilly, Tim Meyer	233
7	The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. 1999 ·PubMed ·(unknown), David Propper, Alexander McDonald, Nicola Dobbs, Trivadi S. Ganesan, Dennis Talbot, (unknown), Francesco Caponigro, C. Hutchison, Christopher Twelves, Anthony Man, Doriano Fabbro, Adrian L. Harris, Frances R. Balkwill	41
8	Role of double-stranded RNA-activated protein kinase in human hematological malignancies. 1997 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Anthony Man, A. V. Hoffbrand, K. Ganeshaguru	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact